Search results for: 'Sample-to-Answer'

This research service analyzes the market for proteomics sample preparation solutions within the United States. The United States market was divided into the commodity chemistries and devices, targeted sample extraction or fractionation kits, kits for the affinity capture of high abundant proteins, and pre-spectrometry sample digest and cleanup so...

Numerous facilities, ranging from research laboratories to hospitals, academic centers and commercial entities, collect human tissues and biomaterials. This study will discuss opportunities, challenges and forecasts for the biobanking automation market globally for the period 2010-2018. Varying requirements of biobanks have urged market participant...

07 Sep 2015  |  North America  |  Market Research

US Nucleic Acid Purification and Isolation Markets

Critical Sample Preparation Step Benefits from Downstream Applications

Infographics

×

The total market, as defined by this study, includes nucleic acid purification and isolation reagents (including kits and homebrew reagents) and nucleic acid purification and isolation instruments in the United States. The study period runs from 2011 to 2021, with 2014 as the base year and 2015–2021 as the forecast period. This research service off...

21 Aug 2018  |  Asia Pacific  |  Market Research

Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023

Product Innovation is the Answer for Sustainability in a Dynamic Market

Infographics

×

The governments and providers in Asia-Pacific (APAC) are focused on reducing medical expenses while improving population health and well-being. A shortage of medical professionals is seen across multiple specialties in various APAC countries; moreover, clinicians are concentrated in urban areas leading to disproportionate clinician–to-patient ratio...

Economists and healthcare academics have stated for years that the normal market dynamics for supply and demand curves do not apply for the consumption of healthcare. In other words, the price goes up as demand increases, attracting new suppliers that increase the supply, which brings the price back to normal because healthcare in the United States...

The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling options. Increasing technological advancements have created several opportunities for market expansion in direct...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...